February 19th, 2010
Congratulations to Andrew W. Pippas, M.D., medical director and director of Clinical Oncology Research at the John B. Amos Cancer Center in Columbus, Georgia, who was recently named a Distinguished Cancer Scholar by the Georgia Cancer Coalition.
The honor comes with a $500,000 grant to support clinical research efforts at the John B. Amos Cancer Center.
The research dollars will be used to enhance the existing clinical trials program, with an emphasis on gastrointestinal malignancies—Dr. Pippas’ specialty.
Currently, there are approximately 48 open clinical trials at the John B. Amos Cancer Center, in areas including:
Brain Cancer
Breast Cancer
Cervical Cancer
Colorectal Cancer
Head/Neck Cancer
Leukemia
Lung Cancer
Lymphoma
Melanoma
Ovarian Cancer
Prostate Cancer
Funds also will be used to expand the multidisciplinary programs that enable patients to see all their physicians and clinical teams during one visit in one location, rather than multiple visits to multiple locations.
Quick Facts About Dr. Andrew Pippas
Earned his Doctor of Medicine degree from the University of Utah School of Medicine in Salt Lake City.
Completed his residency in Internal Medicine and a fellowship in Medical Oncology and Hematology at the Duke University Medical Center in Durham, North Carolina.
Is a board-certified medical oncologist.
Is a recipient of the National Institutes of Health (NiH) Physician Scientist Award.
Is an active member of the American Society of Clinical Oncology and the American Society of Hematology.

Dr. Andrew W. Pippas is the medical director and director of Clinical Oncology Research at the John B. Amos Cancer Center.
Congratulations to Andrew W. Pippas, M.D., medical director and director of Clinical Oncology Research at the John B. Amos Cancer Center in Columbus, Georgia, who was recently named a Distinguished Cancer Scholar by the Georgia Cancer Coalition.
The honor comes with a $500,000 grant to support clinical research efforts at the John B. Amos Cancer Center.
The research dollars will be used to enhance the existing clinical trials program, with an emphasis on gastrointestinal malignancies.
Currently, there are approximately 48 open clinical trials at the John B. Amos Cancer Center, in areas including:
- Brain Cancer
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Head/Neck Cancer
- Leukemia
- Lung Cancer
- Lymphoma
- Melanoma
- Ovarian Cancer
- Prostate Cancer
Funds also will be used to expand the multidisciplinary programs that enable patients to see all their physicians and clinical teams during one visit in one location, rather than multiple visits to multiple locations.
Quick Facts About Dr. Andrew Pippas
- Earned his Doctor of Medicine degree from the University of Utah School of Medicine in Salt Lake City.
- Completed his residency in Internal Medicine and a fellowship in Medical Oncology and Hematology at the Duke University Medical Center in Durham, North Carolina.